Skinvisible Offers Eight-Hour Photostable Avobenzone Sunscreen
This article was originally published in The Rose Sheet
Executive Summary
Skinvisible Pharmaceuticals is in discussions with potential licensees interested in marketing avobenzone-based sunscreen products with eight hours of photostability. Although a popular choice for providing UVA protection, avobenzone typically degrades in sunlight in less than two hours, the firm says.
You may also be interested in...
L’Oreal Sues Competitors J&J, Merck For Sunscreen Patent Infringement
L’Oreal says competitors Johnson & Johnson and Merck revealed in previous litigation that both use octocrylene to keep the avobenzone in their sunscreen formulas from degrading, representing two cases of willful patent infringement. L’Oreal is suing the companies in Delaware federal court for injunction and damages.
Croda Plugs Offerings As Solutions To Challenges Of Sunscreen Rule
Ingredient supplier Croda is promoting its Solaveil XT-40W titanium dioxide dispersion as a good option for green sunscreen marketers looking to meet new broad-spectrum protection requirements in FDA’s final rule for OTC sunscreens. The firm plugged a number of its offerings during a Nov. 30 presentation.
FDA Strengthens Sunscreen Testing And Label Requirements
As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.